Pilot Study of BCAA on Sleep
A Pilot Study of Dietary Supplementation With Branched Chain Amino Acids on Sleep
Portland VA Medical Center
300 participants
Mar 1, 2019
INTERVENTIONAL
Conditions
Summary
Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experimental period.
Eligibility
Inclusion Criteria4
- Veteran
- English Speaking
- Accessible via phone
- Sleep problems
Exclusion Criteria5
- Decisional impairment
- Nickel allergy
- Maple syrup urine disease or family history of disease
- Allergy to sucralose
- Currently taking BCAAs
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
60 grams of BCAA (2:1:1 ratio of Leucine:Isoleucine:Valine) consumed in two doses (30 grams each) mixed into 20 oz of water for up to21days (42 total drinks).
60 grams of rice protein consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21days (42 total drinks).
60 grams of microcrystalline cellulose, consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21days (42 total drinks).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03990909